CK, cytokeratin; IHC, immunohistochemical.
* The mean age of the 49 patients was 62.8 ± 10.2 years. Therefore, the patients were divided into two groups: patients aged 63 years or older, and those younger than 63 years.
† Includes CK-positive/p53-positive, CK-positive/p53-negative, and CK-negative/p53-positive IHC stainings in pN0 lymph nodes.